Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn J Wiggins

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Advances in Chronic Kidney Disease|February 19, 2005
The influence of obesity on the development and survival outcomes of chronic kidney diseaseKathryn J Wiggins, David W Johnson
Kidney International|April 16, 2009
Aliskiren: a novel renoprotective agent or simply an alternative to ACE inhibitors?Kathryn J Wiggins, Darren J Kelly
Nephrology (Carlton, Vic.)|February 12, 2005
Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failureKathryn J Wiggins, Markus Rumpsfeld, Sophie Blizzard, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 27, 2007
Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trialsKathryn J Wiggins, David W Johnson, Jonathan C Craig, et al.
Journal of Nephrology|September 20, 2007
Rifampicin-associated segmental necrotizing glomerulonephritis in staphylococcal endocarditisKathryn J Wiggins, Jason W Galanos, Prue A Hill, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2007
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysisKathryn J Wiggins, Stephen P McDonald, Fiona G Brown, et al.
Nephrology (Carlton, Vic.)|February 24, 2011
Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathyAndrew Advani, Kathryn J Wiggins, Alison J Cox, et al.
Nephrology (Carlton, Vic.)|October 2, 2008
Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 ratsKathryn J Wiggins, Victoria Tiauw, Yuan Zhang, et al.
Nephrology (Carlton, Vic.)|August 20, 2005
Intradialytic serum protein concentrations differ between nightly nocturnal and conventional haemodialysisKathryn J Wiggins, Christine A Somerville, Richard Knight, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 16, 2013
Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trialsYeoungjee Cho, David W Johnson, Sunil Badve, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Advances in Chronic Kidney Disease|February 19, 2005
The influence of obesity on the development and survival outcomes of chronic kidney diseaseKathryn J Wiggins, David W Johnson
Kidney International|April 16, 2009
Aliskiren: a novel renoprotective agent or simply an alternative to ACE inhibitors?Kathryn J Wiggins, Darren J Kelly
Nephrology (Carlton, Vic.)|February 12, 2005
Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failureKathryn J Wiggins, Markus Rumpsfeld, Sophie Blizzard, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 27, 2007
Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trialsKathryn J Wiggins, David W Johnson, Jonathan C Craig, et al.
Journal of Nephrology|September 20, 2007
Rifampicin-associated segmental necrotizing glomerulonephritis in staphylococcal endocarditisKathryn J Wiggins, Jason W Galanos, Prue A Hill, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2007
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysisKathryn J Wiggins, Stephen P McDonald, Fiona G Brown, et al.
Nephrology (Carlton, Vic.)|February 24, 2011
Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathyAndrew Advani, Kathryn J Wiggins, Alison J Cox, et al.
Nephrology (Carlton, Vic.)|October 2, 2008
Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 ratsKathryn J Wiggins, Victoria Tiauw, Yuan Zhang, et al.
Nephrology (Carlton, Vic.)|August 20, 2005
Intradialytic serum protein concentrations differ between nightly nocturnal and conventional haemodialysisKathryn J Wiggins, Christine A Somerville, Richard Knight, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 16, 2013
Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trialsYeoungjee Cho, David W Johnson, Sunil Badve, et al.
Pageof 5